NCT03183752View on ClinicalTrials.gov

Insulin Resistance and Metformin Use on Volume of Benign Thyroid Nodules

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

August 13, 2015

Primary Completion Date

October 17, 2018

Study Completion Date

April 17, 2019

Conditions
Thyroid NoduleInsulin Resistance
Interventions
DRUG

Metformin

500 mg metformin three times daily

DRUG

Placebo

500 mg placebo three times daily

Trial Locations (1)

21941913

Patricia Santos, Rio de Janeiro

All Listed Sponsors
lead

Hospital Universitário Clementino Fraga Filho

OTHER

NCT03183752 - Insulin Resistance and Metformin Use on Volume of Benign Thyroid Nodules | Biotech Hunter | Biotech Hunter